Siemens Healthineers AG (FRA:SHL)
Market Cap | 50.97B |
Revenue (ttm) | 22.67B |
Net Income (ttm) | 1.99B |
Shares Out | n/a |
EPS (ttm) | 1.77 |
PE Ratio | 25.68 |
Forward PE | n/a |
Dividend | 0.95 (2.13%) |
Ex-Dividend Date | Feb 19, 2025 |
Volume | 43,882 |
Average Volume | 1,202,216 |
Open | 45.81 |
Previous Close | 45.63 |
Day's Range | 45.48 - 45.99 |
52-Week Range | 41.21 - 58.48 |
Beta | n/a |
RSI | 41.37 |
Earnings Date | May 7, 2025 |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and... [Read more]
Financial Performance
In 2024, Siemens Healthineers AG's revenue was 22.36 billion, an increase of 3.15% compared to the previous year's 21.68 billion. Earnings were 1.94 billion, an increase of 28.69%.
Financial StatementsNews

EQS-DD: Siemens Healthineers AG: Darleen Caron, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 22.04.2025 / 17:45 CET/CEST The issuer is solely responsi...

EQS-CMS: Siemens Healthineers AG: Release of a capital market information
EQS Post-admission Duties announcement: Siemens Healthineers AG / Disclosure pursuant to Art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 202...

Siemens Healthineers and Vivolight Medical Collaborate to Launch DSA-OCT Integrated Multi-Modal Diagnostic and Treatment Platform, Ushering in a New Era of Intelligent Cath Labs
Shenzhen, China--(Newsfile Corp. - February 28, 2025) - Recently, the world's first DSA-OCT integrated multi-modal diagnostic and treatment platform (ARTIS icono floor), jointly developed by Siemens H...

Siemens sells 2% stake in Siemens Healthineers
German engineering company Siemens announced late on Wednesday it launched a sale of a 2% stake in healthcare subsidiary Siemens Healthineers.

Siemens Healthineers AG (SEMHF) Q1 2025 Earnings Call Transcript
Siemens Healthineers AG (OTCPK:SEMHF) Q1 2025 Earnings Conference Call February 6, 2025 2:30 AM ET Company Participants Marc Koebernick - Head, IR Bernd Montag - CEO Jochen Schmitz - CFO Conference Ca...

Siemens Healthineers says it would welcome stake reduction by Siemens
Siemens Healthineers' CEO said on Thursday that the medical-technology company had a "very positive" view on considerations by parent Siemens to reduce its stake.

Siemens Healthineers reports Q1 revenue slightly above consensus
German medical technology company Siemens Healthineers on Thursday reported first quarter revenue slightly above consensus, as its U.S. revenues increased by 16% while those from China declined 6% due...

Siemens Healthineers Digital Transformation Strategies, Innovation Programs and Technology Initiatives
The report provides insights into Siemens Healthineers' tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives. The report provides i...

InkSpace Imaging Receives FDA 510(k) Clearance for 1.5T 24-channel MR Coil for Siemens Healthineers
PLEASANTON, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- InkSpace Imaging, a leader in MRI coil innovation, today announced that the United States (US) Food and Drug Administration (FDA) has cleared InkS...

Siemens Healthineers Offers Imaging-Driven Upside For Patient Investors
Recent underperformance is likely due to below-expectations revenue, mixed margins, and lower fiscal 2025 guidance, despite strong imaging and radiation oncology performance. Imaging remains a major g...

Siemens Healthineers AG (SEMHF) Q4 2024 Earnings Call Transcript
Siemens Healthineers AG (OTCPK:SEMHF) Q4 2024 Results Conference Call November 6, 2024 2:00 AM ET Company Participants Marc Koebernick - Head-Investor Relations Bernd Montag - Chief Executive Officer ...

Siemens Healthineers meets full-year earnings forecast
German medical technology company Siemens Healthineers reported a full-year adjusted earnings before interest and taxes (EBIT) and revenue growth in line with analysts' consensus on Wednesday.

Siemens Healthineers: My Current Pick In Medtech Ahead Of Q4 2024
Siemens Healthineers is a company that I have written about a few times in the past, and I already have a bit of a position in SEMHF. My intention, before 4Q24, which is coming out in a few days, is t...

Patient Testing Set to be Overhauled with Automation from Siemens Healthineers that Tackles Lab Workflow and Staffing Challenges
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Siemens Healthineers now offers Atellica Integrated Automation on the Atellica CI Analyzer,1 to consolidate 25 tasks typically handled manually by clinical laboratory...

Together with Siemens Healthineers, Varian Highlights Software and Imaging Innovations to Enable Personalized Patient Care at ASTRO 2024
PALO ALTO, Calif.--(BUSINESS WIRE)-- #ASTRO24--Together with Siemens Healthineers, Varian Highlights Software and Imaging Innovations to Enable Personalized Patient Care at ASTRO 2024.
Fertility-related stocks are becoming more attractive, Barclays says
CNBC's Silvia Amaro takes a look at why investors are growing more interested in fertility-related stocks.

Siemens Healthineers to buy Novartis unit for over $223 million, FT reports
Siemens Healthineers will pay more than 200 million euros ($223.8 million) to acquire the diagnostic arm of Advanced Accelerator Applications, owned by Novartis , the Financial Times reported on Satur...
Siemens Healthineers sees return to growth in China in Q4, CFO says
Jochen Schmitz, CFO of Siemens Healthineers, discusses the German healthcare firm's latest round of earnings.

Siemens Healthineers AG (SEMHF) Q3 2024 Earnings Call Transcript
Siemens Healthineers AG (OTCPK:SEMHF) Q3 2024 Earnings Conference Call July 31, 2024 2:30 AM ET Company Participants Marc Koebernick - Head-Investor Relations Bernd Montag - Chief Executive Officer Jo...

Siemens Healthineers hit by China order delays in Q3, but sees 2025 turnaround
German medical technology company Siemens Healthineers said on Wednesday its sales were hit by continued order delays in China in the third quarter, sending its shares more than 6% lower.

Human-Centered Engineering in the Lab Can Close the Distance Between Providers and Care: Siemens Healthineers to Exhibit How at ADLM 2024
CHICAGO--(BUSINESS WIRE)--ADLM 2024 Clinical Lab Expo--Siemens Healthineers has pushed the boundaries of medical engineering to improve patient care for more than 125 years. At the ADLM 2024 Clinical ...

AI in Medical Diagnostics Market Insights and Forecast, 2024-2033 - Top Ten Competitors Account for 56.02% of the Total Revenue, Led by Siemens Healthineers, Followed Closely by Merative L.P.
Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "AI in Medical Diagnostics Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.

Siemens Healthineers: The Upside Is Clear To Me Over The Long Term
Siemens Healthineers reported good revenue growth and margin expansion in Q2 2024, with strong performance in Imaging, Varian, and Advanced Therapies segments. Despite a recent decline in share price,...

Siemens Healthineers: Softer Orders A Risk, But The Story Remains Sound
Healthcare capex demand has supported healthy order growth at Siemens Healthineers, as the company leverages new innovative platforms in Imaging (MRI, CT) and radiation oncology (Varian). The Street w...

Siemens Healthineers (SHL) 2024 Product Pipeline Analysis and Ongoing Clinical Trails Insights
Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Siemens Healthineers AG (SHL) - Product Pipeline Analysis, 2024 Update" company profile has been added to ResearchAndMarkets.com's offering. This report ...